MedWatch

Strained Danish job market poses challenge for Novo's newest expansion

The drugmaker is seeking to create 160 new jobs by a expanding a facility in Denmark – but in a squeezed domestic job market, the firm will have to make itself known while future technicians still being educated.

Photo: Tidsvilde Stine/Ekstra Bladet/Ritzau Scanpix

On Tuesday, Novo Nordisk announced it will expand its existing facility in Bagsværd, a Copenhagen suburb; once completed in 2024, the project is expected to create 160 new jobs.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs